Comparison 3. Droperidol versus midazolam.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Tranquillisation or asleep: 1. tranquillised/asleep	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
1.1 At 5 minutes	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.37 [0.21, 0.64]
1.2 At 10 minutes	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.96 [0.72, 1.28]
2 Tranquillisation or asleep: 2 time to tranquillisation/sleep			Other data	No numeric data
3 Global state: use of additional medication	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.54 [0.24, 1.20]
3.1 By 60 minutes	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.54 [0.24, 1.20]
4 Adverse effects	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
4.1 Cardiovascular ‐ arrhythmia (bradycardia)	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	2.81 [0.12, 67.98]
4.2 Cardiovascular ‐ hypotension	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.70 [0.16, 3.03]
4.3 Central nervous system ‐ dystonic reaction	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	6.56 [0.34, 124.93]
4.4 Central nervous system ‐ seizure	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.5 Gastric ‐ aspiration	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.6 Gastric ‐ vomiting	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.7 Respiratory ‐ airway management	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.13 [0.01, 2.55]
4.8 Respiratory ‐ assistance with ventilation	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.9 Respiratory ‐ hypoxia	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.70 [0.16, 3.03]